Analyst Ratings for Akoya Biosciences
Portfolio Pulse from Benzinga Insights
Analysts have rated Akoya Biosciences (NASDAQ:AKYA) with 1 bullish and 4 somewhat bullish ratings in the last quarter. The average 12-month price target for AKYA is $8.6, representing a 34.85% decrease from the previous target of $13.20. No ratings were given in the last 30 days or 1 month ago, while 2 months ago, the stock received 4 somewhat bullish ratings, and 3 months ago, it received 1 bullish rating.
December 14, 2023 | 2:00 pm
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
Akoya Biosciences has received positive ratings from analysts, with an average price target of $8.6, which is a significant decrease from the previous target.
The ratings are somewhat bullish, indicating a positive sentiment among analysts, which could be good for the stock. However, the significant decrease in the average price target may reflect a revision of future expectations, potentially due to new market information or company performance. This mixed signal could lead to a neutral short-term impact as the market digests the information.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100